Farther Finance Advisors, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1992825 SAN FRANCISCO, CA

Position in VRTX

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$2,121,958

+$117,654 QoQ

Shares Held

4,752

+7.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $14,686,998 across 278 Biotechnology names. VRTX ranks #1 (14.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	4,752	$2,121,958
2	REGN	Regeneron Pharmaceuticals, Inc.	1,870	$1,444,836
3	MRNA	Moderna, Inc.	20,211	$1,026,718
4	SMMT	Summit Therapeutics Inc.	50,316	$953,991
5	HALO	Halozyme Therapeutics, Inc.	13,333	$861,711
6	ARWR	Arrowhead Pharmaceuticals, Inc.	11,971	$750,581
7	EXEL	Exelixis, Inc.	16,443	$705,240
8	BMRN	Biomarin Pharmaceutical Inc	7,857	$443,841

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,121,958	4,752	+7.5%	Shares	Sole	2026-04-07
2025-12-31	$2,004,304	4,421	+30.3%	Shares	Sole	2026-01-23
2025-09-30	$1,328,834	3,393	+16.8%	Shares	Sole	2025-10-14
2025-06-30	$1,293,751	2,906	+1.2%	Shares	Sole	2025-07-11
2025-03-31	$1,391,918	2,871	+19.2%	Shares	Sole	2025-04-14
2024-12-31	$970,104	2,409	+4.6%	Shares	Sole	2025-02-10
2024-09-30	$1,070,614	2,302	-0.4%	Shares	Sole	2024-10-29
2024-06-30	$1,083,680	2,312	+176.6%	Shares	Sole	2024-07-31
2024-03-31	$349,456	836	+14.8%	Shares	Sole	2024-05-14
2023-12-31	$296,215	728	+241.8%	Shares	Sole	2024-02-15
2023-09-30	$74,068	213	+46.9%	Shares	Sole	2023-11-14
2023-06-30	$51,026	145	+5.8%	Shares	Sole	2024-05-14
2023-03-31	$43,164	137	-21.3%	Shares	Sole	2024-05-14
2022-12-31	$50,247	174	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.